Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries with laboratories in Poland (Krakow & Poznan) and Croatia (Zagreb) and offices in Cambridge, UK, Greater Boston Area & San Francisco Bay Area in the US. The company offers drug discovery support at every stage of the early discovery phase up to the preclinical research phase.
Selvita in Zagreb, previously doing business as Fidelta, is a scientific research organization with a long research tradition in the fields of biology, chemistry, biomedicine, veterinary medicine, pharmacy and related scientific fields, with the purpose of discovering new chemical and biological entities intended for the treatment of various diseases. We are a service organization; our scientists are working on projects, in collaboration with external partners, aimed at discovering a new drug or establishing test systems and platforms that improve the predictability of the research process.
Before joining the Selvita Group in 2021, we were part of PLIVA, GSK and Galapagos Group.